|
Year : 2022 |
Volume: 5 |
Issue Number: 3 | Page: 110-111
CORRIGENDUM
Corrigendum: Initial report of a clinical trial evaluating the safety and efficiency of neoadjuvant camrelizumab and apatinib in patients with recurrent high-grade gliomas: A prospective, phase II, single-arm study
|
|
|
| Number of times
this article was viewed |
540 |
| Number of times
this article has been printed from the site |
24 |
| Number of times
this article was emailed to others |
0 |
| Remarks given by
readers [ Read ] |
0 |
|
|
Article
Access Statistics